Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases

Pharmacology and Therapeutics

Volumn 148, Issue , 2015, Pages 114-131

  Beurel, Eleonore ^a   Grieco, Steven F ^a   Jope, Richard S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Depression; G protein coupled receptors; Glycogen synthase kinase 3; Lithium; Neuroinflammation

Indexed keywords

AXIN; BETA CATENIN; G PROTEIN COUPLED RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; HORMONE RECEPTOR; IONOTROPIC RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 1; PROTEIN P53; WNT PROTEIN; CELL SURFACE RECEPTOR;

ALTERNATIVE RNA SPLICING; BINDING SITE; CELL MIGRATION; CELLULAR DISTRIBUTION; CIRCADIAN RHYTHM; DRUG TARGETING; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; INTRACELLULAR SIGNALING; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MENTAL DISEASE; NEOPLASM; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WNT SIGNALING PATHWAY; ANIMAL; INFLAMMATION; METABOLISM; PHOSPHORYLATION;

ANIMALS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INFLAMMATION; NEOPLASMS; NERVOUS SYSTEM DISEASES; PHOSPHORYLATION; RECEPTORS, CELL SURFACE;

EID: 84923265392     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.11.016     Document Type: Review

References (306)

1. M. Adli, D.L. Hollinde, T. Stamm, K. Wiethoff, M. Tsahuridu, and J. Kirchheiner Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-β -50T/C single nucleotide polymorphism Biol Psychiatry 62 2007 1295 1302
2. A. Agarwal-Mawal, H.Y. Qureshi, P.W. Cafferty, Z. Yuan, D. Han, and R. Lin 14-3-3 connects glycogen synthase kinase-3β to tau within a brain microtubule-associated tau phosphorylation complex J Biol Chem 278 2003 12722 12728
3. L.T. Alon, S. Pietrokovski, S. Barkan, L. Avrahami, O. Kaidanovich-Beilin, and J.R. Woodgett Selective loss of glycogen synthase kinase-3α in birds reveals distinct roles for GSK-3 isozymes in tau phosphorylation FEBS Lett 585 2011 1158 1162
4. S. Amar, R.H. Belmaker, and G. Agam The possible involvement of glycogen synthase kinase-3 (GSK-3) in diabetes, cancer and central nervous system diseases Curr Pharm Des 17 2011 2264 2277
5. J.N. Anastas, and R.T. Moon WNT signalling pathways as therapeutic targets in cancer Nat Rev Cancer 13 2012 11 26
6. H. Armanious, J. Deschenes, P. Gelebart, S. Ghosh, J. Mackey, and R. Lai Clinical and biological significance of GSK-3β inactivation in breast cancer - an immunohistochemical study Hum Pathol 41 2010 1657 1663
7. J. Avila, F. Wandosell, and F. Hernández Role of glycogen synthase kinase-3 in Alzheimer's disease pathogenesis and glycogen synthase kinase-3 inhibitors Expert Rev Neurother 10 2010 703 710
8. L. Avrahami, D. Farfara, M. Shaham-Kol, R. Vassar, D. Frenkel, and H. Eldar-Finkelman Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies J Biol Chem 288 2013 1295 1306
9. I. Azoulay-Alfaguter, Y. Yaffe, A. Licht-Murava, M. Urbanska, J. Jaworski, and S. Pietrokovski Distinct molecular regulation of glycogen synthase kinase-3α isozyme controlled by its N-terminal region: functional role in calcium/calpain signaling J Biol Chem 286 2011 13470 13480
10. V. Banerji, S.M. Frumm, K.N. Ross, L.S. Li, A.C. Schinzel, and C.K. Hahn The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia J Clin Invest 122 2012 935 947
11. Z. Bao, S. Lim, W. Liao, Y. Lin, C. Thiemermann, and B.P. Leung Glycogen synthase kinase-3β inhibition attenuates asthma in mice Am J Respir Crit Care Med 176 2007 431 438
12. F.H. Bardai, and S.R. D'Mello Selective toxicity by HDAC3 in neurons: regulation by Akt and GSK3β J Neurosci 31 2011 1746 1751
13. J.M. Beaulieu, R.R. Gainetdinov, and M.G. Caron Akt/GSK3 signaling in the action of psychotropic drugs Annu Rev Pharmacol Toxicol 49 2009 327 347
14. J.M. Beaulieu, S. Marion, R.M. Rodriguiz, I.O. Medvedev, T.D. Sotnikova, and V. Ghisi A β-arrestin 2 signaling complex mediates lithium action on behavior Cell 132 2008 125 136
15. J.M. Beaulieu, T.D. Sotnikova, S. Marion, R.J. Lefkowitz, R.R. Gainetdinov, and M.G. Caron An Akt/β-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior Cell 122 2005 261 273
16. J.M. Beaulieu, T.D. Sotnikova, W.D. Yao, L. Kockeritz, J.R. Woodgett, and R.R. Gainetdinov Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade Proc Natl Acad Sci U S A 101 2004 5099 5104
17. J.M. Beaulieu, X. Zhang, R.M. Rodriguiz, T.D. Sotnikova, M.J. Cools, and W.C. Wetsel Role of GSK3β in behavioral abnormalities induced by serotonin deficiency Proc Natl Acad Sci U S A 105 2008 1333 1338
18. M.M. Bellet, and P. Sassone-Corsi Mammalian circadian clock and metabolism - the epigenetic link J Cell Sci 123 2010 3837 3848
19. F. Benedetti, A. Bernasconi, C. Lorenzi, A. Pontiggia, A. Serretti, and C. Colombo A single nucleotide polymorphism in glycogen synthase kinase 3β promoter gene influences onset of illness in patients affected by bipolar disorder Neurosci Lett 355 2004 37 40
20. F. Benedetti, A. Serretti, C. Colombo, C. Lorenzi, V. Tubazio, and E. Smeraldi A glycogen synthase kinase 3β promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression Neurosci Lett 368 2004 123 126
21. F. Benedetti, A. Serretti, A. Pontiggia, A. Bernasconi, C. Lorenzi, and C. Colombo Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3β -50 T/C SNP Neurosci Lett 376 2005 51 55
22. E. Berry-Kravis, A. Sumis, C. Hervey, M. Nelson, S.W. Porges, and N. Weng Open-label treatment trial of lithium to target the underlying defect in fragile X syndrome J Dev Behav Pediatr 29 2008 293 302
23. Y. Bersudsky, A. Shaldubina, N. Kozlovsky, J.R. Woodgett, G. Agam, and R.H. Belmaker Glycogen synthase kinase-3β heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results Behav Pharmacol 19 2008 217 224
24. E. Beurel Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases Front Mol Neurosci 4 2011 18
25. E. Beurel, and R.S. Jope The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways Prog Neurobiol 79 2006 173 189
26. E. Beurel, and R.S. Jope Differential regulation of STAT family members by glycogen synthase kinase-3 J Biol Chem 283 2008 21934 21944
27. E. Beurel, O. Kaidanovich-Beilin, W.I. Yeh, L. Song, V. Palomo, and S.M. Michalek Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3 J Immunol 190 2013 5000 5011
28. E. Beurel, S.M. Michalek, and R.S. Jope Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3) Trends Immunol 31 2010 24 31
29. E. Beurel, M.A. Mines, L. Song, and R.S. Jope Glycogen synthase kinase-3 levels and phosphorylation undergo.large fluctuations in mouse brain during development Bipolar Disord 14 2012 822 830
30. E. Beurel, W.I. Yeh, S.M. Michalek, L.E. Harrington, and R.S. Jope Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells J Immunol 186 2011 1391 1398
31. G.N. Bijur, and R.S. Jope Proapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3β J Biol Chem 276 2001 37436 37442
32. G.N. Bijur, and R.S. Jope Glycogen synthase kinase-3β is highly activated in nuclei and mitochondria Neuroreport 14 2003 2415 2419
33. C.A. Bradley, S. Peineau, C. Taghibiglou, C.S. Nicolas, D.J. Whitcomb, and Z.A. Bortolotto A pivotal role of GSK-3 in synaptic plasticity Front Mol Neurosci 5 2012 13
34. J. Brognard, E. Sierecki, T. Gao, and A.C. Newton PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms Mol Cell 25 2007 917 931
35. V. Bryja, D. Gradl, A. Schambony, E. Arenas, and G. Schulte Beta-arrestin is a necessary component of Wnt/β-catenin signaling in vitro and in vivo Proc Natl Acad Sci U S A 104 2007 6690 6695
36. X. Cai, M. Li, J. Vrana, and M.D. Schaller Glycogen synthase kinase 3- and extracellular signal-regulated kinase-dependent phosphorylation of paxillin regulates cytoskeletal rearrangement Mol Cell Biol 26 7 2006 2857 2868
37. Z. Castaño, P.R. Gordon-Weeks, and R.M. Kypta The neuron-specific isoform of glycogen synthase kinase-3β is required for axon growth J Neurochem 113 2010 117 130
38. M.D. Castellone, H. Teramoto, B.O. Williams, K.M. Druey, and J.S. Gutkind Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-β-catenin signaling axis Science 310 2005 1504 1510
39. N. Cernotta, A. Clocchiatti, C. Florean, and C. Brancolini Ubiquitin-dependent degradation of HDAC4, a new regulator of random cell motility Mol Biol Cell 22 2011 278 289
40. A. Chakraborty, C. Latapy, J. Xu, S.H. Snyder, and J.M. Beaulieu Inositol hexakisphosphate kinase-1 regulates behavioral responses via GSK3 signaling pathways Mol Psychiatry 19 2014 284 293
41. C. Charvet, M. Wissler, P. Brauns-Schubert, S.J. Wang, Y. Tang, and F.C. Sigloch Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53 Mol Cell 42 2011 584 596
42. P. Chen, Z. Gu, W. Liu, and Z. Yan Glycogen synthase kinase 3 regulates N-methyl-d-aspartate receptor channel trafficking and function in cortical neurons Mol Pharmacol 72 2007 40 51
43. M. Chen, J.A. Maloney, D.Y. Kallop, J.K. Atwal, S.J. Tam, and K. Baer Spatially coordinated kinase signaling regulates local axon degeneration J Neurosci 32 2012 13439 13453
44. S. Chen, G.C. Owens, H. Makarenkova, and D.B. Edelman HDAC6 regulates mitochondrial transport in hippocampal neurons PLoS One 5 2010 e10848
45. L. Chen, G.D. Salinas, and X. Li Regulation of serotonin 1B receptor by glycogen synthase kinase-3 Mol Pharmacol 76 2009 1150 1161
46. Y. Chen, S. Yue, L. Xie, X.H. Pu, T. Jin, and S.Y. Cheng Dual phosphorylation of suppressor of fused (Sufu) by PKA and GSK3β regulates its stability and localization in the primary cilium J Biol Chem 286 2011 13502 13511
47. L. Chen, W. Zhou, P.C. Chen, I. Gaisina, S. Yang, and X. Li Glycogen synthase kinase-3β is a functional modulator of serotonin-1B receptors Mol Pharmacol 79 2011 974 986
48. H. Cheng, J. Woodgett, M. Maamari, and T. Force Targeting GSK-3 family members in the heart: a very sharp double-edged sword J Mol Cell Cardiol 51 2011 607 613
49. J. Cho, P. Rameshwar, and J. Sadoshima Distinct roles of glycogen synthase kinase (GSK)-3α and GSK-3β in mediating cardiomyocyte differentiation in murine bone marrow-derived mesenchymal stem cells J Biol Chem 284 2009 36647 36658
50. C.H. Choi, B.P. Schoenfeld, A.J. Bell, P. Hinchey, M. Kollaros, and M.J. Gertner Pharmacological reversal of synaptic plasticity deficits in the mouse model of Fragile X syndrome by group II mGluR antagonist or lithium treatment Brain Res 1380 2011 106 119
51. H.Y. Chou, S.L. Howng, T.S. Cheng, Y.L. Hsiao, A.S. Lieu, and J.K. Loh GSKIP is homologous to the Axin GSK3β interaction domain and functions as a negative regulator of GSK3β Biochemistry 45 2006 11379 11389
52. H.M. Chow, D. Guo, J.C. Zhou, G.Y. Zhang, H.F. Li, and K. Herrup CDK5 activator protein p25 preferentially binds and activates GSK3β Proc Natl Acad Sci U S A 2014 10.1038/onc.2014.279 (in press)
53. D.M. Chuang, Z. Wang, and C.T. Chiu GSK-3 as a target for lithium-induced neuroprotection against excitotoxicity in neuronal cultures and animal models of ischemic stroke Front Mol Neurosci 4 2011 15
54. A. Cole, S. Frame, and P. Cohen Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event Biochem J 377 2004 249 255
55. A.R. Cole, A. Knebel, N.A. Morrice, L.A. Robertson, A.J. Irving, and C.N. Connolly GSK-3 phosphorylation of the Alzheimer epitope within collapsin response mediator proteins regulates axon elongation in primary neurons J Biol Chem 279 2004 50176 50180
56. D.A. Cross, D.R. Alessi, P. Cohen, M. Andjelkovich, and B.A. Hemmings Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B Nature 378 1995 785 789
57. S. Cuzzocrea, E. Mazzon, R. Di Paola, C. Muia, C. Crisafulli, and L. Dugo Glycogen synthase kinase-3β inhibition attenuates the degree of arthritis caused by type II collagen in the mouse Clin Immunol 120 2006 57 67
58. R. Dajani, E. Fraser, S.M. Roe, M. Yeo, V.M. Good, and V. Thompson Structural basis for recruitment of glycogen synthase kinase 3β to the axin-APC scaffold complex EMBO J 22 2003 494 501
59. L. Dan, O. Klimenkova, M. Klimiankou, J.H. Klusman, M.M. van den Heuvel-Eibrink, and D. Reinhardt The role of sirtuin 2 activation by nicotinamide phosphoribosyltransferase in the aberrant proliferation and survival of myeloid leukemia cells Haematologica 97 2012 551 559
60. R.S. Darrington, V.M. Campa, M.M. Walker, N. Bengoa-Vergniory, I. Gorrono-Etxebarria, and P. Uysal-Onganer Distinct expression and activity of GSK-3α and GSK-3β in prostate cancer Int J Cancer 131 2012 E872 E883
61. P. De Sarno, R.C. Axtell, C. Raman, K.A. Roth, D.R. Alessi, and R.S. Jope Lithium prevents and ameliorates experimental autoimmune encephalomyelitis (EAE) J Immunol 181 2008 338 345
62. P. De Sarno, G.N. Bijur, A.A. Zmijewska, X. Li, and R.S. Jope In vivo regulation of GSK3 phosphorylation by cholinergic and NMDA receptors Neurobiol Aging 27 2006 413 422
63. P. De Sarno, X. Li, and R.S. Jope Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium Neuropharmacology 43 2002 1158 1164
64. T. del Ser, K.C. Steinwachs, H.J. Gertz, M.V. Andrés, B. Gómez-Carrillo, and M. Medina Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study J Alzheimers Dis 33 2013 205 215
65. J. Dembowy, H.A. Adissu, J.C. Liu, E. Zacksenhaus, and J.R. Woodgett Effect of glycogen synthase kinase-3 inactivation on mouse mammary gland development and oncogenesis Oncogene 2014 10.1038/onc.2014.279 (in press)
66. Y. Deng, Z. Xiong, P. Chen, J. Wei, S. Chen, and Z. Yan β-Amyloid impairs the regulation of N-methyl-d-aspartate receptors by glycogen synthase kinase 3 Neurobiol Aging 35 2014 449 459
67. Y.Z. Deng, F. Yao, J.J. Li, Z.F. Mao, P.T. Hu, and L.Y. Long RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex Gastroenterology 142 2012 812 823
68. A.A. DePaoli-Roach Synergistic phosphorylation and activation of ATP-Mg-dependent phosphoprotein phosphatase by F A/GSK-3 and casein kinase II (PC0.7) J Biol Chem 259 1984 12144 12152
69. I. Dewachter, L. Ris, T. Jaworski, C.M. Seymour, A. Kremer, and P. Borghgraef GSK3β, a centre-staged kinase in neuropsychiatric disorders, modulates long term memory by inhibitory phosphorylation at serine-9 Neurobiol Dis 35 2009 193 200
70. S. Dewhurst, S.B. Maggirwar, G. Schifitto, H.E. Gendelman, and H.A. Gelbard Glycogen synthase kinase 3β (GSK-3β) as a therapeutic target in neuroAIDS J Neuroimmune Pharmacol 2 2007 93 96
71. J. Dill, H. Wang, F. Zhou, and S. Li Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS J Neurosci 28 2008 8914 8928
72. Q. Ding, X. He, J.M. Hsu, W. Xia, C.T. Chen, and L.Y. Li Degradation of Mcl-1 by β-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization Mol Cell Biol 27 2007 4006 4017
73. J. Du, Y. Wei, L. Liu, Y. Wang, R. Khairova, and R. Blumenthal A kinesin signaling complex mediates the ability of GSK-3β to affect mood-associated behaviors Proc Natl Acad Sci U S A 107 2010 11573 11578
74. 2+ in metalloproteins, implications for lithium therapy J Am Chem Soc 133 2011 9506 9515
75. T. Duka, V. Duka, J.N. Joyce, and A. Sidhu Alpha-synuclein contributes to GSK-3β-catalyzed Tau phosphorylation in Parkinson's disease models FASEB J 23 2009 2820 2830
76. R.S. Duman, and L.M. Monteggia A neurotrophic model for stress-related mood disorders Biol Psychiatry 59 2006 1116 1127
77. B.J. Eickholt, F.S. Walsh, and P. Doherty An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling J Cell Biol 157 2002 211 217
78. H. Eldar-Finkelman, and E.G. Krebs Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action Proc Natl Acad Sci U S A 94 1997 9660 9664
79. H. Eldar-Finkelman, A. Licht-Murava, S. Pietrokovski, and M. Eisenstein Substrate competitive GSK-3 inhibitors - strategy and implications Biochim Biophys Acta 1804 2010 598 603
80. H. Eldar-Finkelman, and A. Martinez GSK-3 inhibitors: preclinical and clinical focus on CNS Front Mol Neurosci 4 2011 32
81. T.Y. Eom, and R.S. Jope GSK3β N-terminus binding to p53 promotes its acetylation Mol Cancer 8 2009 14
82. T.Y. Eom, and R.S. Jope Blocked inhibitory serine-phosphorylation of glycogen synthase kinase-3α/β impairs in vivo neural precursor cell proliferation Biol Psychiatry 66 2009 494 502
83. S. Etienne-Manneville, and A. Hall Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarity Nature 421 2003 753 756
84. G. Fan, L.M. Ballou, and R.Z. Lin Phospholipase C-independent activation of glycogen synthase kinase-3β and C-terminal Src kinase by Gαq J Biol Chem 278 2003 52432 52436
85. M. Farago, I. Dominguez, E. Landesman-Bollag, X. Xu, A. Rosner, and R.D. Cardiff Kinase-inactive glycogen synthase kinase 3β promotes Wnt signaling and mammary tumorigenesis Cancer Res 65 2005 5792 5801
86. K.L. Feijs, H. Kleine, A. Braczynski, A.H. Forst, N. Herzog, and P. Verheugd ARTD10 substrate identification on protein microarrays: regulation of GSK3β by mono-ADP-ribosylation Cell Commun Signal 11 2013 5
87. D.M. Ferkey, and D. Kimelman Glycogen synthase kinase-3β mutagenesis identifies a common binding domain for GBP and Axin J Biol Chem 277 2002 16147 16152
88. T. Force, and J.R. Woodgett Unique and overlapping functions of GSK-3 isoforms in cell differentiation and proliferation and cardiovascular development J Biol Chem 284 2009 9643 9647
89. O.V. Forlenza, V.J. de Paula, R. Machado-Vieira, B.S. Diniz, and W.F. Gattaz Does lithium prevent Alzheimer's disease? Drugs Aging 29 2012 335 342
90. S. Frame, and P. Cohen GSK3 takes centre stage more than 20 years after its discovery Biochem J 359 2001 1 16
91. S. Frame, P. Cohen, and R.M. Biondi A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation Mol Cell 7 2001 1321 1327
92. S. Frame, and D. Zheleva Targeting glycogen synthase kinase-3 in insulin signalling Expert Opin Ther Targets 10 2006 429 444
93. J. Franca-Koh, M. Yeo, E. Fraser, N. Young, and T.C. Dale The regulation of glycogen synthase kinase-3 nuclear export by Frat/GBP J Biol Chem 277 2002 43844 43848
94. A.V. Franklin, M.K. King, V. Palomo, A. Martinez, L. McMahon, and R.S. Jope Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in Fragile X mice Biol Psychiatry 75 2014 198 206
95. E. Fraser, N. Young, R. Dajani, J. Franca-Koh, J. Ryves, and R.S. Williams Identification of the Axin and Frat binding region of glycogen synthase kinase-3 J Biol Chem 277 2002 2176 2185
96. Z. Freyberg, S.J. Ferrando, and J.A. Javitch Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action Am J Psychiatry 167 2010 388 396
97. M. Fujimuro, J. Liu, J. Zhu, H. Yokosawa, and S.D. Hayward Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen J Virol 79 2005 10429 10441
98. A.J. Galliher-Beckley, J.G. Williams, J.B. Collins, and J.A. Cidlowski Glycogen synthase kinase 3β-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles Mol Cell Biol 28 2008 7309 7322
99. G. Garcea, M.M. Manson, C.P. Neal, C.J. Pattenden, C.D. Sutton, and A.R. Dennison Glycogen synthase kinase-3β; a new target in pancreatic cancer? Curr Cancer Drug Targets 7 2007 209 215
100. J.C. Garza, M. Guo, W. Zhang, and X.Y. Lu Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3β/β-catenin signaling Mol Psychiatry 17 2012 790 808
101. R. Gómez-Sintes, and J.J. Lucas NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy J Clin Invest 120 2010 2432 2445
102. P. Goñi-Oliver, J. Avila, and F. Hernández Calpain-mediated truncation of GSK-3 in post-mortem brain samples J Neurosci Res 87 2009 1156 1161
103. P. Goñi-Oliver, J.J. Lucas, J. Avila, and F. Hernández N-terminal cleavage of GSK-3 by calpain: a new form of GSK-3 regulation J Biol Chem 282 2007 22406 22413
104. N. Goode, K. Hughes, J.R. Woodgett, and P.J. Parker Differential regulation of glycogen synthase kinase-3β by protein kinase C isotypes J Biol Chem 267 1992 16878 16882
105. C.A. Grimes, and R.S. Jope The multifaceted roles of glycogen synthase kinase 3β in cellular signaling Prog Neurobiol 65 2001 391 426
106. J. Grisouard, and D. Mayer Specific involvement of glycogen synthase kinase-3 in the function and activity of sex steroid hormone receptors reveals the complexity of their regulation J Steroid Biochem Mol Biol 117 2009 87 92
107. J. Grisouard, S. Medunjanin, A. Hermani, A. Shukla, and D. Mayer Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor Mol Endocrinol 21 2007 2427 2439
108. M.F. Gulen, K. Bulek, H. Xiao, M. Yu, J. Gao, and L. Sun Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance Immunity 37 2012 800 812
109. X. Guo, A. Ramirez, D.S. Waddell, Z. Li, X. Liu, and X.F. Wang Axin and GSK3- control Smad3 protein stability and modulate TGF- signaling Genes Dev 22 2008 106 120
110. C. Gupta, J. Kaur, and K. Tikoo Regulation of MDA-MB231 cell proliferation by GSK-3β involves epigenetic modifications under high glucose conditions Exp Cell Res 324 2014 75 83
111. H. Hampel, M. Ewers, K. Bürger, P. Annas, A. Mörtberg, and A. Bogstedt Lithium trial in Alzheimer's disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study J Clin Psychiatry 70 2009 922 931
112. D.P. Hanger, K. Hughes, J.R. Woodgett, J.P. Brion, and B.H. Anderton Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase Neurosci Lett 147 1992 58 62
113. N. Happel, S. Stoldt, B. Schmidt, and D. Doenecke M phase-specific phosphorylation of histone H1.5 at threonine 10 by GSK-3 J Mol Biol 386 2009 339 350
114. K. Haraguchi, M. Ohsugi, Y. Abe, K. Semba, T. Akiyama, and T. Yamamoto Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3β-mediated phosphorylation of β-catenin Oncogene 27 2008 274 284
115. R.J. Hartmaier, A.S. Richter, R.M. Gillihan, J.Z. Sallit, S.E. McGuire, and J. Wang A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone Mol Endocrinol 26 2012 220 227
116. R. Hashimoto, C. Hough, T. Nakazawa, T. Yamamoto, and D.M. Chuang Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation J Neurochem 80 2002 589 597
117. D.S. Himmelstein, S.M. Ward, J.K. Lancia, K.R. Patterson, and L.I. Binder Tau as a therapeutic target in neurodegenerative disease Pharmacol Ther 136 2012 8 22
118. K.P. Hoeflich, J. Luo, E.A. Rubie, M.S. Tsao, O. Jin, and J.R. Woodgett Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation Nature 406 2000 86 90
119. G.U. Höglinger, H.J. Huppertz, S. Wagenpfeil, M.V. Andrés, V. Belloch, and T. León Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial Mov Disord 29 2014 479 487
120. C. Hooper, V. Markevich, F. Plattner, R. Killick, E. Schofield, and T. Engel Glycogen synthase kinase-3 inhibition is integral to long-term potentiation Eur J Neurosci 25 2007 81 86
121. S.L. Howng, C.C. Hwang, C.Y. Hsu, M.Y. Hsu, C.Y. Teng, and C.H. Chou Involvement of the residues of GSKIP, AxinGID, and FRATtide in their binding with GSK3β to unravel a novel C-terminal scaffold-binding region Mol Cell Biochem 339 2010 23 33
122. X. Hu, P.K. Paik, J. Chen, A. Yarilina, L. Kockeritz, and T.T. Lu IFN-γ suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins Immunity 24 2006 563 574
123. K. Hughes, E. Nikolakaki, S.E. Plyte, N.F. Totty, and J.R. Woodgett Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation EMBO J 12 1993 803 808
124. C. Hundsrucker, P. Skroblin, F. Christian, H.M. Zenn, V. Popara, and M. Joshi Glycogen synthase kinase 3β interaction protein functions as an A-kinase anchoring protein J Biol Chem 285 2010 5507 5521
125. D.E. Hurtado, L. Molina-Porcel, J.C. Carroll, C. Macdonald, A.K. Aboagye, and J.Q. Trojanowski Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease J Neurosci 32 2012 7392 7402
126. C. Iitaka, K. Miyazaki, T. Akaike, and N. Ishida A role for glycogen synthase kinase-3β in the mammalian circadian clock J Biol Chem 280 2005 29397 29402
127. B. Inkster, T.E. Nichols, P.G. Saemann, D.P. Auer, F. Holsboer, and P. Muglia Association of GSK3β polymorphisms with brain structural changes in major depressive disorder Arch Gen Psychiatry 66 2009 721 728
128. B. Inkster, T.E. Nichols, P.G. Saemann, D.P. Auer, F. Holsboer, and P. Muglia Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3β substrates and major depression Neuroimage 53 2010 908 917
129. E. Iwahana, M. Akiyama, K. Miyakawa, A. Uchida, J. Kasahara, and K. Fukunaga Effect of lithium on the circadian rhythms of locomotor activity and glycogen synthase kinase-3 protein expression in the mouse suprachiasmatic nuclei Eur J Neurosci 19 2004 2281 2287
130. K.K. Jernigan, C.S. Cselenyi, C.A. Thorne, A.J. Hanson, E. Tahinci, and N. Hajicek Gβγ activates GSK3 to promote LRP6-mediated β-catenin transcriptional activity Sci Signal 3 2010 ra37
131. H. Jiang, W. Guo, X. Liang, and Y. Rao Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3β and its upstream regulators Cell 120 2005 123 135
132. R.S. Jope Lithium and GSK3: one inhibitor, two inhibitory actions, multiple outcomes Trends Pharmacol Sci 24 2003 441 443
133. R.S. Jope Lithium, the seminal GSK3 inhibitor A. Martinez, A. Castro, M. Medina, Glycogen Synthase Kinase 3 (GSK-3) and Its Inhibitors 2006 John Wiley and Sons, Inc. 223 242
134. R.S. Jope Glycogen synthase kinase-3 in the etiology and treatment of mood disorders Front Mol Neurosci 4 2011 16 26
135. R.S. Jope, and G.V.W. Johnson The glamour and gloom of glycogen synthase kinase-3 (GSK3) Trends Biochem Sci 29 2004 95 102
136. R.S. Jope, C.J. Yuskaitis, and E. Beurel Glycogen synthase kinase-3 (GSK3): Inflammation, diseases and therapeutics Neurochem Res 32 2007 577 595
137. O. Kaidanovich-Beilin, T.V. Lipina, K. Takao, M. van Eede, S. Hattori, and C. Laliberté Abnormalities in brain structure and behavior in GSK-3α mutant mice Mol Brain 2 2009 35
138. O. Kaidanovich-Beilin, and J.R. Woodgett GSK-3: functional insights from cell biology and animal models Front Mol Neurosci 4 2011 40
139. A.D. Kandasamy, and R. Schulz Glycogen synthase kinase-3β is activated by matrix metalloproteinase-2 mediated proteolysis in cardiomyoblasts Cardiovasc Res 83 2009 698 706
140. N.D. Kashikar, W. Zhang, P.P. Massion, A.L. Gonzalez, and P.K. Datta Role of STRAP in regulating GSK3β function and Notch3 stabilization Cell Cycle 10 2011 1639 1654
141. G.M. Kelly, D.A. Buckley, P.A. Kiely, D.R. Adams, and R. O'Connor Serine phosphorylation of the insulin-like growth factor I (IGF-1) receptor C-terminal tail restrains kinase activity and cell growth J Biol Chem 287 2012 28180 28194
142. L.V. Kessing, J.L. Forman, and P.K. Andersen Does lithium protect against dementia? Bipolar Disord 12 2010 87 94
143. J.S. Kim, S. Piao, E. Lee, B.Y. Yoon, H.R. Moon, and J. Lee Development of Akt-activated GSK3β inhibitory peptide Biochem Biophys Res Commun 434 2014 735 739
144. W.Y. Kim, X. Wang, Y. Wu, B.W. Doble, S. Patel, and J.R. Woodgett GSK-3 is a master regulator of neural progenitor homeostasis Nat Neurosci 12 2009 1390 1397
145. N.G. Kim, C. Xu, and B.M. Gumbiner Identification of targets of the Wnt pathway destruction complex in addition to β-catenin Proc Natl Acad Sci U S A 106 2009 5165 5170
146. W.Y. Kim, F.Q. Zhou, J. Zhou, Y. Yokota, Y.M. Wang, and T. Yoshimura Essential roles for GSK-3 s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth Neuron 52 2006 981 996
147. T.D. King, G.N. Bijur, and R.S. Jope Caspase-3 activation induced by inhibition of mitochondrial complex I is facilitated by glycogen synthase kinase-3β and attenuated by lithium Brain Res 919 2001 106 114
148. M.K. King, and R.S. Jope Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome Genes Brain Behav 12 2013 723 731
149. M.K. King, M. Pardo, Y. Cheng, K. Downey, R.S. Jope, and E. Beurel Glycogen synthase kinase-3 inhibitors: rescuers of cognitive impairments Pharmacol Ther 141 2014 1 12
150. Y. Kise, A. Morinaka, S. Teglund, and H. Miki Sufu recruits GSK3β for efficient processing of Gli3 Biochem Biophys Res Commun 387 2009 569 574
151. P.S. Klein, and D.A. Melton A molecular mechanism for the effect of lithium on development Proc Natl Acad Sci U S A 93 1996 8455 8459
152. H.W. Ko, E.Y. Kim, J. Chiu, J.T. Vanselow, A. Kramer, and I. Edery A hierarchical phosphorylation cascade that regulates the timing of PERIOD nuclear entry reveals novel roles for proline-directed kinases and GSK-3β/SGG in circadian clocks J Neurosci 30 2010 12664 12675
153. T. Kobayashi, S. Hino, N. Oue, T. Asahara, M. Zollo, and W. Yasui Glycogen synthase kinase 3 and h-prune regulate cell migration by modulating focal adhesions Mol Cell Biol 26 2006 898 911
154. J.B. Kwok, M. Hallupp, C.T. Loy, D.K. Chan, J. Woo, and G.D. Mellick GSK3B polymorphisms alter transcription and splicing in Parkinson's disease Ann Neurol 58 2005 829 839
155. H.M. Lachman, E. Pedrosa, O.A. Petruolo, M. Cockerham, A. Papolos, and T. Novak Increase in GSK3β gene copy number variation in bipolar disorder Am J Med Genet B Neuropsychiatr Genet 144B 2007 259 265
156. H. Lal, J. Zhou, F. Ahmad, R. Zaka, R.J. Vagnozzi, and M. Decaul Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death Circulation 125 2012 65 75
157. J. Lavoie, M. Hébert, and J.M. Beaulieu Glycogen synthase kinase-3β haploinsufficiency lengthens the circadian locomotor activity period in mice Behav Brain Res 253 2013 262 265
158. P.R. Leeds, F. Yu, Z. Wang, C.T. Chiu, Y. Zhang, and Y. Leng A new avenue for lithium: intervention in traumatic brain injury ACS Chem Neurosci 2014 Apr 11 (Epub ahead of print)
159. H. Leis, C. Segrelles, S. Ruiz, M. Santos, and J.M. Paramio Expression, localization, and activity of glycogen synthase kinase 3β during mouse skin tumorigenesis Mol Carcinog 35 2002 180 185
160. E. Levina, M. Oren, and A. Ben-Ze'ev Downregulation of β-catenin by p53 involves changes in the rate of β-catenin phosphorylation and Axin dynamics Oncogene 23 2004 4444 4453
161. X.H. Li, C. Chen, Y. Tu, H.T. Sun, M.L. Zhao, and S.X. Cheng Sirt1 promotes axonogenesis by deacetylation of Akt and inactivation of GSK3 Mol Neurobiol 48 2013 490 499
162. C. Li, P.J. Ebert, and Q.J. Li T cell receptor (TCR) and transforming growth factor β (TGF-β) signaling converge on DNA (cytosine-5)-methyltransferase to control forkhead box protein 3 (foxp3) locus methylation and inducible regulatory T cell differentiation J Biol Chem 288 2013 19127 19139
163. X. Li, A.B. Friedman, W. Zhu, L. Wang, S. Boswell, and R.S. May Lithium regulates glycogen synthase kinase-3β in human peripheral blood mononuclear cells: implication in the treatment of bipolar disorder Biol Psychiatry 61 2007 216 222
164. Q. Li, S. Lin, X. Wang, G. Lian, Z. Lu, and H. Guo Axin determines cell fate by controlling the p53 activation threshold after DNA damage Nat Cell Biol 11 2009 1128 1134
165. Y.C. Li, M.J. Wang, and W.J. Gao Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3β signaling-mediated trafficking of GABAA receptors J Neurochem 122 2012 308 320
166. Q. Li, X. Wang, X. Wu, Y. Rui, W. Liu, and J. Wang Daxx cooperates with the Axin/HIPK2/p53 complex to induce cell death Cancer Res 67 2007 66 74
167. Y.C. Li, D. Xi, J. Roman, Y.Q. Huang, and W.J. Gao Activation of glycogen synthase kinase-3β is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex J Neurosci 29 2009 15551 15563
168. X. Li, W. Zhu, M.S. Roh, A.B. Friedman, K. Rosborough, and R.S. Jope In vivo regulation of glycogen synthase kinase-3β (GSK3β) by serotonergic activity in mouse brain Neuropsychopharm 29 2004 1426 1431
169. M.H. Liang, and D.M. Chuang Differential roles of glycogen synthase kinase-3 isoforms in the regulation of transcriptional activation J Biol Chem 281 2006 30479 30484
170. W. Liao, S. Wang, C. Han, and Y. Zhang 14-3-3 proteins regulate glycogen synthase 3β phosphorylation and inhibit cardiomyocyte hypertrophy FEBS J 272 2005 1845 1854
171. A. Licht-Murava, and H. Eldar-Finkelman Exploiting substrate recognition for selective inhibition of protein kinases Curr Pharm Des 18 2012 2914 2920
172. R.K. Lin, Y.S. Hsieh, P. Lin, H.S. Hsu, C.Y. Chen, and Y.A. Tang The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients J Clin Invest 120 2010 521 532
173. S.Y. Lin, T.Y. Li, Q. Liu, C. Zhang, X. Li, and Y. Chen GSK3-TIP60-ULK1 signaling pathway links growth factor deprivation to autophagy Science 336 2012 477 481
174. C.H. Lin, P.I. Tsai, R.M. Wu, and C.T. Chien LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ß J Neurosci 30 2010 13138 13149
175. R. Linding, L.J. Jensen, G.J. Ostheimer, M.A. van Vugt, C. Jørgensen, and I.M. Miron Systematic discovery of in vivo phosphorylation networks Cell 129 2007 1415 1426
176. F. Lo Monte, T. Kramer, J. Gu, U.R. Anumala, and L. Marinelli Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α J Med Chem 55 2012 4407 4424
177. Y. Lu, M. Muller, D. Smith, B. Dutta, K. Komurov, and S. Iadevaia Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling Oncogene 30 2011 4567 4577
178. P.T. Ly, Y. Wu, H. Zou, R. Wang, W. Zhou, and A. Kinoshita Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes J Clin Invest 123 2013 224 235
179. C. Ma, J. Wang, Y. Gao, T.W. Gao, G. Chen, and K.A. Bower The role of glycogen synthase kinase 3β in the transformation of epidermal cells Cancer Res 67 2007 7756 7764
180. K. MacAulay, and J.R. Woodgett Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes Expert Opin Ther Targets 12 2008 1265 1274
181. B.T. MacDonald, K. Tamai, and X. He Wnt/β-catenin signaling: components, mechanisms, and diseases Dev Cell 17 2009 9 26
182. L. Mai, R.S. Jope, and X. Li BDNF-mediated signal transduction is modulated by GSK3β and mood stabilizing agents J Neurochem 82 2002 75 83
183. B.C. Mak, H.L. Kenerson, L.D. Aicher, E.A. Barnes, and R.S. Yeung Aberrant β-catenin signaling in tuberous sclerosis Am J Pathol 167 2005 107 116
184. B.C. Mak, K. Takemaru, H.L. Kenerson, R.T. Moon, and R.S. Yeung The tuberin-hamartin complex negatively regulates β-catenin signaling activity J Biol Chem 278 2003 5947 5951
185. E.M. Mandelkow, G. Drewes, J. Biernat, N. Gustke, J. Van Lint, and J.R. Vandenheede Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau FEBS Lett 314 1992 315 321
186. A.S. Manoukian, and J.R. Woodgett Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways Adv Cancer Res 84 2002 203 229
187. M. Martin, K. Rehani, R.S. Jope, and S.M. Michalek Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3 Nat Immunol 6 2005 777 784
188. A. Martinez, and D.I. Perez GSK-3 inhibitors: a ray of hope for the treatment of Alzheimer's disease? J Alzheimers Dis 15 2008 181 191
189. H. Maurin, B. Lechat, I. Dewachter, L. Ris, J.V. Louis, and P. Borghgraef Neurological characterization of mice deficient in GSK3α highlight pleiotropic physiological functions in cognition and pathological activity as Tau kinase Mol Brain 6 2013 27
190. G. McColl, D.W. Killilea, A.E. Hubbard, M.C. Vantipalli, S. Melov, and G.J. Lithgow Pharmacogenetic analysis of lithium-induced delayed aging in Caenorhabditis elegans J Biol Chem 283 2008 350 357
191. J.A. McCubrey, L.S. Steelman, F.E. Bertrand, N.M. Davis, S.L. Abrams, and G. Montalto Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention Leukemia 28 2014 15 33
192. E.J. McManus, K. Sakamoto, L.J. Armit, L. Ronaldson, N. Shpiro, and R. Marquez Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis EMBO J 24 2005 1571 1583
193. G.P. Meares, and R.S. Jope Resolution of the nuclear localization mechanism of glycogen synthase kinase-3: functional effects in apoptosis J Biol Chem 282 2007 16989 17001
194. M. Medina, and J. Avila Glycogen synthase kinase-3 (GSK-3) inhibitors for the treatment of Alzheimer's disease Curr Pharm Des 16 2010 2790 2798
195. S. Medunjanin, A. Hermani, B. De Servi, J. Grisouard, G. Rincke, and D. Mayer Glycogen synthase kinase-3 interacts with and phosphorylates estrogen receptor alpha and is involved in the regulation of receptor activity J Biol Chem 280 2005 33006 33014
196. P. Mendez, and L.M. Garcia-Segura Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells Endocrinology 147 2006 3027 3039
197. M.W. Miller, M.R. Caracciolo, W.K. Berlin, and J.A. Hanover Phosphorylation and glycosylation of nucleoporins Arch Biochem Biophys 367 1999 51 60
198. C.N. Mills, S. Nowsheen, J.A. Bonner, and E.S. Yang Emerging roles of glycogen synthase kinase 3 in the treatment of brain tumors Front Mol Neurosci 4 2011 47
199. M.A. Mines, E. Beurel, and R.S. Jope Regulation of cell survival mechanisms in Alzheimer's disease by glycogen synthase kinase-3 Int J Alzheimers Dis 2011 2011 861072
200. M.A. Mines, and R.S. Jope Glycogen synthase kinase-3: a promising therapeutic target for fragile x syndrome Front Mol Neurosci 4 2011 35
201. V. Mondelli, C. Anacker, A.C. Vernon, A. Cattaneo, S. Natesan, and M. Modo Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways Transl Psychiatry 3 2013 e208
202. J. Monteserin-Garcia, O. Al-Massadi, L.M. Seoane, C.V. Alvarez, B. Shan, and J. Stalla Sirt1 inhibits the transcription factor CREB to regulate pituitary growth hormone synthesis FASEB J 27 2013 1561 1571
203. J.A. Morales-García, C. Susín, S. Alonso-Gil, D.I. Pérez, V. Palomo, and C. Pérez Glycogen synthase kinase-3 inhibitors as potent therapeutic agents for the treatment of Parkinson disease ACS Chem Neurosci 4 2013 350 360
204. G. Morfini, G. Szebenyi, R. Elluru, N. Ratner, and S.T. Brady Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility EMBO J 21 2002 281 293
205. F. Mukai, K. Ishiguro, Y. Sano, and S.C. Fujita Alternative splicing isoform of tau protein kinase I/glycogen synthase kinase 3β J Neurochem 81 2002 1073 1083
206. D.J. Mulholland, S. Dedhar, H. Wu, and C.C. Nelson PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer Oncogene 25 2006 329 337
207. C.D. Nelson, M.J. Kim, H. Hsin, Y. Chen, and M. Sheng Phosphorylation of threonine-19 of PSD-95 by GSK-3β is required for PSD-95 mobilization and long-term depression J Neurosci 33 2013 12122 12135
208. T. Nemoto, S. Satoh, T. Maruta, T. Kanai, N. Yoshikawa, and S. Miyazaki Homologous posttranscriptional regulation of insulin-like growth factor-I receptor level via glycogen synthase kinase-3β and mammalian target of rapamycin in adrenal chromaffin cells: effect on tau phosphorylation Neuropharmacology 58 2010 1097 1108
209. S.S. Ng, T. Mahmoudi, E. Danenberg, I. Bejaoui, W. de Lau, and H.C. Korswagen Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade J Biol Chem 284 2009 35308 35313
210. N. Nishiguchi, G. Breen, C. Russ, D. St Clair, and D. Collier Association analysis of the glycogen synthase kinase-3β gene in bipolar disorder Neurosci Lett 394 2006 243 245
211. T. Nishimoto, T. Kihara, A. Akaike, T. Niidome, and H. Sugimoto α-Amino-3-hydroxy-5-methyl-4-isoxazole propionate attenuates glutamate-induced caspase-3 cleavage via regulation of glycogen synthase kinase 3β J Neurosci Res 86 2008 1096 1105
212. T. Nishimoto, T. Kihara, A. Akaike, T. Niidome, and H. Sugimoto AMPA reduces surface expression of NR1 through regulation of GSK3β Neuroreport 20 2009 161 165
213. S. Nonaka, C.J. Hough, and D.M. Chuang Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-d-aspartate receptor-mediated calcium influx Proc Natl Acad Sci U S A 95 1998 2642 2647
214. P.V. Nunes, O.V. Forlenza, and W.F. Gattaz Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder Br J Psychiatry 190 2007 359 360
215. M.A. Nunes, T.A. Viel, and H.S. Buck Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease Curr Alzheimer Res 10 2013 104 107
216. W.T. O'Brien, J. Haung, R. Buccafusca, J. Garskof, A.J. Valvezan, and G.T. Berry Glycogen synthase kinase-3 is essential for β-arrestin-2 complex formation and lithium-sensitive behaviors in mice J Clin Invest 121 2011 3756 3762
217. W.T. O'Brien, A.D. Harper, F. Jové, J.R. Woodgett, S. Maretto, and S. Piccolo Glycogen synthase kinase-3β haploinsufficiency mimics the behavioral and molecular effects of lithium J Neurosci 24 2004 6791 6798
218. W.T. O'Brien, and P.S. Klein Validating GSK3 as an in vivo target of lithium action Biochem Soc Trans 37 2009 1133 1138
219. H. Okamoto, B. Voleti, M. Banasr, M. Sarhan, V. Duric, and M.J. Girgenti Wnt2 expression and signaling is increased by different classes of antidepressant treatments Biol Psychiatry 68 2010 521 527
220. N. Omata, C.T. Chiu, P.R. Moya, Y. Leng, Z. Wang, J.G. Hunsberger, P. Leeds, and D.M. Chuang Lentivirally mediated GSK-3β silencing in the hippocampal dentate gyrus induces antidepressant-like effects in stressed mice Int J Neuropsychopharmacol. 14 5 2011 711 717
221. A.V. Ougolkov, and D.D. Billadeau Targeting GSK-3: a promising approach for cancer therapy? Future Oncol 2 2006 91 100
222. A.V. Ougolkov, N.D. Bone, M.E. Fernandez-Zapico, N.E. Kay, and D.D. Billadeau Inhibition of glycogen synthase kinase-3 activity leads to epigenetic silencing of nuclear factor kappaB target genes and induction of apoptosis in chronic lymphocytic leukemia B cells Blood 110 2007 735 742
223. A.V. Ougolkov, M.E. Fernandez-Zapico, D.N. Savoy, R.A. Urrutia, and D.D. Billadeau Glycogen synthase kinase-3β participates in nuclear factor kappaB-mediated gene transcription and cell survival in pancreatic cancer cells Cancer Res 65 2005 2076 2081
224. S. Park, J. Song, C.O. Joe, and I. Shin Akt stabilizes estrogen receptor alpha with the concomitant reduction in its transcriptional activity Cell Signal 20 2008 1368 1374
225. S. Peineau, C. Taghibiglou, C. Bradley, T.P. Wong, L. Liu, and J. Lu LTP inhibits LTD in the hippocampus via regulation of GSK3β Neuron 53 2007 703 717
226. C.J. Phiel, C.A. Wilson, V.M. Lee, and P.S. Klein GSK-3α regulates production of Alzheimer's disease amyloid-β peptides Nature 423 2003 435 439
227. N. Picard, V. Caron, S. Bilodeau, M. Sanchez, X. Mascle, and M. Aubry Identification of estrogen receptor β as a SUMO-1 target reveals a novel phosphorylated sumoylation motif and regulation by glycogen synthase kinase 3β Mol Cell Biol 32 2012 2709 2721
228. F. Pilot-Storck, E. Chopin, J.F. Rual, A. Baudot, P. Dobrokhotov, and M. Robinson-Rechavi Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor Mol Cell Proteomics 9 2010 1578 1593
229. A. Plotnikov, Y. Li, T.H. Tran, W. Tang, J.P. Palazzo, and H. Rui Oncogene-mediated inhibition of glycogen synthase kinase 3β impairs degradation of prolactin receptor Cancer Res 68 2008 1354 1361
230. P. Polakis The many ways of Wnt in cancer Curr Opin Genet Dev 17 2007 45 51
231. A. Polter, E. Beurel, S. Yang, R. Garner, L. Song, and C.A. Miller Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances Neuropsychopharmacology 35 2010 1761 1774
232. A.P. Popkie, L.C. Zeidner, A.M. Albrecht, A. D'Ippolito, S. Eckardt, and D.E. Newsom Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (GSK-3) regulates DNA methylation of imprinted loci J Biol Chem 285 2010 41337 41347
233. C.L. Raison, and A.H. Miller The evolutionary significance of depression in Pathogen Host Defense (PATHOS-D) Mol Psychiatry 18 1 2013 15 37
234. I. Rogatsky, C.L. Waase, and M.J. Garabedian Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation J Biol Chem 273 1998 14315 14321
235. F. Rosenthal, K.L. Feijs, E. Frugier, M. Bonalli, A.H. Forst, and R. Imhof Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases Nat Struct Mol Biol 20 2013 502 507
236. M. Rosner, M. Hanneder, N. Siegel, A. Valli, and M. Hengstschläger The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners Mutat Res 658 2008 234 246
237. Y. Rui, K.R. Myers, K. Yu, A. Wise, A.L. De Blas, and H.C. Hartzell Activity-dependent regulation of dendritic growth and maintenance by glycogen synthase kinase 3β Nat Commun 4 2013 2628
238. Y. Rui, Z. Xu, S. Lin, Q. Li, H. Rui, and W. Luo Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation EMBO J 23 2004 4583 4594
239. A. Ruiz-Saenz, J. van Haren, L. Sayas, L. Rangel, J. Demmers, and J. Millán Protein 4.1R binds to CLASP2 and regulates dynamics, organization and attachment of microtubules to the cell cortex J Cell Sci 126 2013 4589 4601
240. B.D. Sachs, R.M. Rodriguiz, W.B. Siesser, A. Kenan, E.L. Royer, and J.P. Jacobsen The effects of brain serotonin deficiency on behavioural disinhibition and anxiety-like behaviour following mild early life stress Int J Neuropsychopharmacol 16 2013 2081 2094
241. S. Sahar, L. Zocchi, C. Kinoshita, E. Borrelli, and P. Sassone-Corsi Regulation of BMAL1 protein stability and circadian function by GSK3β-mediated phosphorylation PLoS One 5 2010 e8561
242. Saijilafu, E.M. Hur, C.M. Liu, Z. Jiao, W.L. Xu, and F.Q. Zhou PI3K-GSK3 signalling regulates mammalian axon regeneration by inducing the expression of Smad1 Nat Commun 4 2013 2690
243. T.R. Salas, J. Kim, F. Vakar-Lopez, A.L. Sabichi, P. Troncoso, and G. Jenster Glycogen synthase kinase-3β is involved in the phosphorylation and suppression of androgen receptor activity J Biol Chem 279 2004 19191 19200
244. S. Samaan, L.C. Tranchevent, E. Dardenne, M. Polay Espinoza, E. Zonta, and S. Germann The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways Nucleic Acids Res 42 2014 2197 2207
245. E. Saus, V. Soria, G. Escaramís, J.M. Crespo, J. Valero, and A. Gutiérrez-Zotes A haplotype of glycogen synthase kinase 3β is associated with early onset of unipolar major depression Genes Brain Behav 9 2010 799 807
246. B. Schaffer, M. Wiedau-Pazos, and D.H. Geschwind Gene structure and alternative splicing of glycogen synthase kinase 3β (GSK-3β) in neural and non-neural tissues Gene 302 2003 73 81
247. L. Scheuing, C.T. Chiu, H.M. Liao, G.R. Linares, and D.M. Chuang Preclinical and clinical investigations of mood stabilizers for Huntington's disease: what have we learned? Int J Biol Sci 10 2014 1024 1038
248. L. Shahab, F. Plattner, E.E. Irvine, D.M. Cummings, and F.A. Edwards Dynamic range of GSK3α not GSK3β is essential for bidirectional synaptic plasticity at hippocampal CA3-CA1 synapses Hippocampus 24 12 2014 1413 1416
249. A. Shakoori, W. Mai, K. Miyashita, K. Yasumoto, Y. Takahashi, and A. Ooi Inhibition of GSK-3β activity attenuates proliferation of human colon cancer cells in rodents Cancer Sci 98 2007 1388 1393
250. H. Sharfi, and H. Eldar-Finkelman Sequential phosphorylation of insulin receptor substrate-2 by glycogen synthase kinase-3 and c-Jun NH2-terminal kinase plays a role in hepatic insulin signaling Am J Physiol Endocrinol Metab 294 2008 E307 E315
251. X. Si, W. Chen, X. Guo, L. Chen, G. Wang, and Y. Xu Activation of GSK3β by Sirt2 is required for early lineage commitment of mouse embryonic stem cell PLoS One 8 2013 e76699
252. K.K. Singh An emerging role for Wnt and GSK3 signaling pathways in schizophrenia Clin Genet 83 2013 511 517
253. S.A. Singh, D. Winter, P.M. Bilimoria, A. Bonni, H. Steen, and J.A. Steen FLEXIQinase, a mass spectrometry-based assay, to unveil multikinase mechanisms Nat Methods 9 5 2012 504 508
254. E. Smith, G.A. Coetzee, and B. Frenkel Glucocorticoids inhibit cell cycle progression in differentiating osteoblasts via glycogen synthase kinase-3β J Biol Chem 277 2002 18191 18197
255. M.P. Soutar, W.Y. Kim, R. Williamson, M. Peggie, C.J. Hastie, and H. McLauchlan Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain J Neurochem 115 2010 974 983
256. T.E. Spencer, G. Jenster, M.M. Burcin, C.D. Allis, J. Zhou, and C.A. Mizzen Steroid receptor coactivator-1 is a histone acetyltransferase Nature 389 1997 194 198
257. M.L. Spengler, K.K. Kuropatwinski, M. Schumer, and M.P. Antoch A serine cluster mediates BMAL1-dependent CLOCK phosphorylation and degradation Cell Cycle 8 2009 4138 4146
258. R. Spokoini, S. Kfir-Erenfeld, E. Yefenof, and R.V. Sionov Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis Mol Endocrinol 24 2010 1136 1150
259. S.C. Stadler, C.T. Vincent, V.D. Fedorov, A. Patsialou, B.D. Cherrington, and J.J. Wakshlag Dysregulation of PAD4-mediated citrullination of nuclear GSK3β activates TGF-β signaling and induces epithelial-to-mesenchymal transition in breast cancer cells Proc Natl Acad Sci U S A 110 2013 11851 11856
260. V. Stambolic, L. Ruel, and J.R. Woodgett Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells Curr Biol 6 1996 1664 1668
261. J.L. Stamos, M.L. Chu, M.D. Enos, N. Shah, and W.I. Weis Structural basis of GSK-3 inhibition by N-terminal phosphorylation and by the Wnt receptor LRP6 Elife 3 2014 e01998
262. L.R. Stephens, A. Eguinoa, H. Erdjument-Bromage, M. Lui, F. Cooke, and J. Coadwell The Gβγ sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101 Cell 89 1997 105 114
263. M. Sun, L. Song, Y. Li, T. Zhou, and R.S. Jope Identification of an anti-apoptotic protein complex at death receptors Cell Death Differ 15 2008 1887 1900
264. L. Sun, H. Zhao, Z. Xu, Q. Liu, Y. Liang, and L. Wang Phosphatidylinositol 3-kinase/protein kinase B pathway stabilizes DNA methyltransferase I protein and maintains DNA methylation Cell Signal 19 2007 2255 2263
265. C. Sutherland What are the bona fide GSK3 substrates? Int J Alzheimers Dis 2011 2011 505607
266. T. Suzuki, D. Bridges, D. Nakada, G. Skiniotis, S.J. Morrison, and J.D. Lin Inhibition of AMPK catabolic action by GSK3 Mol Cell 50 2013 407 419
267. E. Szatmari, A. Habas, P. Yang, J.J. Zheng, T. Hagg, and M. Hetman A positive feedback loop between glycogen synthase kinase 3β and protein phosphatase 1 after stimulation of NR2B NMDA receptors in forebrain neurons J Biol Chem 280 2005 37526 37535
268. A. Szczepankiewicz, J.K. Rybakowski, A. Suwalska, M. Skibinska, A. Leszczynska-Rodziewicz, and M. Dmitrzak-Weglarz Association study of the glycogen synthase kinase-3β gene polymorphism with prophylactic lithium response in bipolar patients World J Biol Psychiatry 7 2006 158 161
269. A. Szczepankiewicz, M. Skibinska, J. Hauser, A. Slopien, A. Leszczynska-Rodziewicz, and P. Kapelski Association analysis of the GSK-3β T-50C gene polymorphism with schizophrenia and bipolar disorder Neuropsychobiology 53 2006 51 56
270. V.F. Taelman, R. Dobrowolski, J.L. Plouhinec, L.C. Fuentealba, P.P. Vorwald, and I. Gumper Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes Cell 143 2010 1136 1148
271. E. ter Haar, J.T. Coll, D.A. Austen, H.M. Hsiao, L. Swenson, and J. Jain Structure of GSK3β reveals a primed phosphorylation mechanism Nat Struct Biol 8 2001 593 596
272. E. Tolosa, I. Litvan, G.U. Höglinger, D. Burn, A. Lees, and M.V. Andrés A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy Mov Disord 29 2014 470 478
273. S.J. Tsai, Y.J. Liou, C.J. Hong, Y.W. Yu, and T.J. Chen Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder Pharmacogenomics J 8 2008 384 390
274. S.K. Tyagarajan, H. Ghosh, G.E. Yevenes, S.Y. Imanishi, H.U. Zeilhofer, and B. Gerrits ERK and GSK3β regulate gephyrin postsynaptic aggregation and GABAergic synaptic function in a calpain-dependent mechanism J Biol Chem 288 2013 9634 9647
275. S.K. Tyagarajan, H. Ghosh, G.E. Yevenes, I. Nikonenko, C. Ebeling, and C. Schwerdel Regulation of GABAergic synapse formation and plasticity by GSK3β-dependent phosphorylation of gephyrin Proc Natl Acad Sci U S A 108 2011 379 384
276. A.J. Valvezan, and P.S. Klein GSK-3 and Wnt signaling in neurogenesis and bipolar disorder Front Mol Neurosci 5 2012 1
277. A.J. Valvezan, F. Zhang, J.A. Diehl, and P.S. Klein Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity J Biol Chem 287 2012 3823 3832
278. T. Vincent, A. Kukalev, M. Andäng, R. Pettersson, and P. Percipalle The glycogen synthase kinase (GSK) 3β represses RNA polymerase I transcription Oncogene 27 2008 5254 5259
279. D. Voskas, L.S. Ling, and J.R. Woodgett Does GSK-3 provide a shortcut for PI3K activation of Wnt signalling? F1000 Biol Rep 2 2010 82
280. E.R. Wagner, G. Zhu, B.Q. Zhang, Q. Luo, Q. Shi, and E. Huang The therapeutic potential of the Wnt signaling pathway in bone disorders Curr Mol Pharmacol 4 2011 14 25
281. S. Wakatsuki, F. Saitoh, and T. Araki ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation Nat Cell Biol 13 2011 1415 1423
282. Z. Wang, M. Iwasaki, F. Ficara, C. Lin, C. Matheny, and S.H. Wong GSK-3 promotes conditional association of CREB and its coactivators with MEIS1 to facilitate HOX-mediated transcription and oncogenesis Cancer Cell 17 2010 597 608
283. S. Wang, Y. Li, P.H. Hsu, S.Y. Lee, Y. Kim, and E.Y. Lee Progesterone receptor A stability is mediated by glycogen synthase kinase-3β in the Brca1-deficient mammary gland J Biol Chem 288 2013 26265 26274
284. M.J. Wang, Y.C. Li, M.A. Snyder, H. Wang, F. Li, and W.J. Gao Group II metabotropic glutamate receptor agonist LY379268 regulates AMPA receptor trafficking in prefrontal cortical neurons PLoS One 8 2013 e61787
285. L. Wang, H.K. Lin, Y.C. Hu, S. Xie, L. Yang, and C. Chang Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3β in prostate cells J Biol Chem 279 2004 32444 32452
286. Q.M. Wang, I.K. Park, C.J. Fiol, P.J. Roach, and A.A. DePaoli-Roach Isoform differences in substrate recognition by glycogen synthase kinases 3α and 3β in the phosphorylation of phosphatase inhibitor 2 Biochemistry 33 1994 143 147
287. Z. Wang, K.S. Smith, M. Murphy, O. Piloto, T.C. Somervaille, and M.L. Cleary Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy Nature 455 2008 1205 1209
288. K. Watase, J.R. Gatchel, Y. Sun, E. Emamian, R. Atkinson, and R. Richman Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model PLoS Med 4 2007 e182
289. P. Watcharasit, G.N. Bijur, L. Song, J. Zhu, X. Chen, and R.S. Jope Glycogen synthase kinase-3β (GSK3β) binds to and promotes the actions of p53 J Biol Chem 278 2003 48872 48879
290. P. Watcharasit, G.N. Bijur, J.W. Zmijewski, L. Song, A. Zmijewska, and X. Chen Direct, activating interaction between glycogen synthase kinase-3β and p53 after DNA damage Proc Natl Acad Sci U S A 99 2002 7951 7955
291. J. Wei, W. Liu, and Z. Yan Regulation of AMPA receptor trafficking and function by glycogen synthase kinase 3 J Biol Chem 285 2010 26369 26376
292. B.J. Whittle, C. Varga, A. Posa, A. Molnar, M. Collin, and C. Thiemermann Reduction of experimental colitis in the rat by inhibitors of glycogen synthase kinase-3β Br J Pharmacol 147 2006 575 582
293. K. Willert, and R. Nusse Wnt proteins Cold Spring Harb Perspect Biol 4 2012 a007864
294. J.R. Woodgett Judging a protein by more than its name: GSK-3 Sci STKE 2001 re12
295. A. Wood-Kaczmar, M. Kraus, K. Ishiguro, K.L. Philpott, and P.R. Gordon-Weeks An alternatively spliced form of glycogen synthase kinase-3β is targeted to growing neurites and growth cones Mol Cell Neurosci 42 2009 184 194
296. R.C. Wu, Q. Feng, D.M. Lonard, and B.W. O'Malley SRC-3 coactivator functional lifetime is regulated by a phospho-dependent ubiquitin time clock Cell 129 2007 1125 1140
297. X. Ye, W. Tai, and D. Zhang The early events of Alzheimer's disease pathology: from mitochondrial dysfunction to BDNF axonal transport deficits Neurobiol Aging 33 2012 1122.e1 1122.e10
298. Z. Yuan, A. Agarwal-Mawal, and H.K. Paudel 14-3-3 binds to and mediates phosphorylation of microtubule-associated tau protein by Ser9-phosphorylated glycogen synthase kinase 3β in the brain J Biol Chem 279 2004 26105 26114
299. C.J. Yuskaitis, M.A. Mines, M.K. King, J.D. Sweatt, C.A. Miller, and R.S. Jope Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X Syndrome Biochem Pharmacol 79 2010 632 646
300. L.C. Zeidner, J.L. Buescher, and C.J. Phiel A novel interaction between Glycogen Synthase Kinase-3α (GSK-3α) and the scaffold protein Receptor for Activated C-Kinase 1 (RACK1) regulates the circadian clock Int J Biochem Mol Biol 2 2011 318 327
301. X. Zeng, K. Tamai, B. Doble, S. Li, H. Huang, and R. Habas A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation Nature 438 2005 873 877
302. J.S. Zhang, M. Herreros-Vilanueva, A. Koenig, Z. Deng, A.A. de Narvajas, and T.S. Gomez Differential activity of GSK-3 isoforms regulates NF-κB and TRAIL- or TNFα induced apoptosis in pancreatic cancer cells Cell Death Dis 5 2014 e1142
303. F. Zhang, C.J. Phiel, L. Spece, N. Gurvich, and P.S. Klein Inhibitory phosphorylation of glycogen synthase kinase-3 (GSK-3) in response to lithium. Evidence for autoregulation of GSK-3 J Biol Chem 278 2003 33067 33077
304. J. Zhou, T.A. Freeman, F. Ahmad, X. Shang, E. Mangano, and E. Gao GSK-3α is a central regulator of age-related pathologies in mice J Clin Invest 123 2013 1821 1832
305. F.Q. Zhou, J. Zhou, S. Dedhar, Y.H. Wu, and W.D. Snider NGF-induced axon growth is mediated by localized inactivation of GSK-3β and functions of the microtubule plus end binding protein APC Neuron 42 2004 897 912
306. L.Q. Zhu, S.H. Wang, D. Liu, Y.Y. Yin, Q. Tian, and X.C. Wang Activation of glycogen synthase kinase-3 inhibits long-term potentiation with synapse-associated impairments J Neurosci 27 2007 12211 12220